Science & Technology Current Affairs MCQs

Notes:
Eli Lilly’s weight-loss drug Mounjaro became India’s top-selling drug by value in October 2025. It overtook GlaxoSmithKline’s (GSK) Augmentin, a widely used antibiotic. Mounjaro earned ₹1 billion ($11.38 million) in October, while Augmentin made ₹800 million. By volume, Augmentin sold 5,784 units, whereas Mounjaro sold only 85 units due to its high price. Mounjaro helps control blood sugar and slow digestion and belongs to the GLP-1 receptor agonist class used for obesity and diabetes. It was launched in India in March 2025 and has earned ₹3.33 billion till October. Mounjaro’s consumption was 10 times higher than rival Wegovy by Novo Nordisk, launched in June 2025. Eli Lilly sold 262,000 units, while Novo Nordisk sold 26,000 units in October.

Notes:
Recently, a scintillometer was installed at the Tamil Nadu Rice Research Institute (TRRI) in Aduthurai, Tamil Nadu. It is an optical instrument used to measure heat and moisture exchange between the land surface and the atmosphere. The device transmits a light beam between two fixed points to collect data. Turbulent air causes minute fluctuations in the beam, called scintillations, which are analysed to estimate heat transfer. It was installed as part of the TRRI Critical Zone Observatory (CZO) to enhance climate and crop research.

Notes:
Shri Manohar Lal, Minister of Power and Housing & Urban Affairs, inaugurated India’s first and largest Vanadium Redox Flow Battery (VRFB) system. The VRFB has a capacity of 3 Megawatt-hour (MWh) at NTPC’s NETRA Research & Development Centre in Greater Noida. This milestone advances India’s long-duration energy storage (LDES) solutions and strengthens renewable energy integration and national grid resilience. Vanadium Redox Flow Battery (VRFB) is a modern technology offering an alternative to lithium-ion batteries, expanding the pool of usable elements for battery systems.

Notes:
The World Health Organisation (WHO) launched its Pandemic Preparedness and Emergency Response site at All India Institute of Medical Sciences (AIIMS), New Delhi. This site is part of a global WHO network being set up to conduct rapid investigations and studies during pandemics or epidemics. The goal is to ensure a timely and effective public health response to global health emergencies. The launch was attended by WHO Representative to India, Payden, and AIIMS Director, Dr. M. Srinivas. The site will also operate during non-pandemic periods to maintain continuous readiness and system strength.

Notes:
On November 17, 2025, Karnataka’s Department of Electronics, IT & BT, with KEONICS, launched KEO, a compact, affordable and AI-ready personal computer designed entirely in Karnataka. KEO stands for Knowledge-driven, Economical, Open-source, built on an open-source RISC-V processor with a Linux-based OS. It features an on-device AI core that works without internet and includes BUDDH, an AI agent trained on the Karnataka DSERT syllabus to help students in low-connectivity areas. KEO will be deployed across schools, universities, businesses, homes and government offices, supporting locally adaptable, home-grown computing.

Notes:
India’s first indigenous CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based gene therapy for Sickle Cell Disease (SCD), named BIRSA 101, was recently launched by the Union Minister of State (Independent Charge) for Science & Technology. It is developed by CSIR (Council of Scientific and Industrial Research) – Institute of Genomics and Integrative Biology (IGIB). BIRSA 101 uses CRISPR-Cas9 gene-editing technology to precisely correct the genetic mutation causing SCD. The therapy is administered as a one-time infusion, after which the body produces normal red blood cells instead of sickle-shaped ones.

Notes:
Recently, researchers from the Central Marine Fisheries Research Institute (CMFRI), Kochi discovered a new deep-sea squid species in the Arabian Sea and named it Taningia silasii (Indian octopus squid). The species was found at a depth of nearly 390 metres off the Kollam coast. It belongs to the family Octopoteuthidae. It is only the second formally recognised species in the Taningia genus. The first species in this genus was Taningia danae, earlier found in the Atlantic Ocean.

Notes:
Researchers at Indian Institute of Technology Madras developed India’s first Indigenous Vessel Traffic Management System (VTMS) for ports. The system was built by the National Technology Centre for Ports, Waterways and Coasts (NTCPWC) as per guidelines of the Ministry of Ports, Shipping and Waterways (MoSPW), Government of India. It gives India full control over source code, data, and vessel movement information, ensuring high maritime security. The VTMS is cost-effective, secure, scalable, and easy to maintain.

Notes:
Telangana’s 1 Bio, India’s first single-use bioprocess design and scale-up facility, was inaugurated at Genome Valley, Hyderabad. It was created to solve the lack of affordable bioprocess scale-up infrastructure despite Telangana’s strong biotech talent. The facility supports start-ups and big companies with end-to-end process development and pilot validation. It was developed by the Government of Telangana, Telangana Lifesciences, Department of Biotechnology (DBT), Government of India, and Telangana Industrial Infrastructure Corporation (TGIIC). It has 500-litre bioreactors, advanced processing systems, and analytical labs.

Notes:
Samudrayaan is India’s first manned deep-ocean submersible mission to reach 6,000 metres depth. Testing is delayed due to late supply of syntactic foam from France, now expected by year-end after testing in Norway. The project is led by National Institute of Ocean Technology under the Ministry of Earth Sciences. A steel model has been tested up to 100 metres; a 500-metre trial is planned by April next year. The final titanium hull, built by Indian Space Research Organisation, will be tested in Russia. The mission will carry three crew members to collect seabed soil and rocks for future deep-sea mining.